Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
In recent preclinical studies, the role of nitric oxide (NO) in nicotine dependence has become increasingly evident. Inhibition of NO synthesis blocks acquisition of conditioned place preference, and attenuates the nicotine abstinence syndrome in rodents. These findings have not been followed up in human studies. In order to obtain preliminary data on NO inhibition in human smokers, we conducted a randomized, double-blind, crossover study (N = 12) of minocycline, a tetracycline derivative antibiotic, that inhibits the neuronal nitric oxide (NO) synthase enzyme with resultant inhibition of NO production. Medication effects were assessed through a smoking choice procedure as well as subjective and physiological responses to nicotine administered via the intravenous route (IV). Minocycline treatment did not affect smoking self-administration in our choice procedure and did not affect most of the subjective responses to IV nicotine or sample smoking. Following IV nicotine administration, there was a greater reduction in craving for cigarettes under minocycline, compared to placebo. Similarly, smokers had greater reduction in their craving for cigarettes following sample smoking under minocycline treatment. These findings provide limited support for the potential use of minocycline as a treatment of nicotine dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Practice Guideline: Otitis Media with Effusion (Update)
Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., et al. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815623467 · Cited by 2,006
Signs and Symptoms of Tobacco Withdrawal
Hughes, J. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800030107013 · Cited by 1,669
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub3 · Cited by 721 · cited 2×
“…intravenous nicotine Despite advances in pharmacotherapy for nicotine dependence, including nicotine replacement therapy (NRT), sustained release (SR) bupropion, and varenicline (Cahill et al. 2007; Fiore 2008; Stead et al. 2008), generally 70-90% resume smoking within a year of treatment.”
BackgroundThe NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453 · cited 2×
“Further, two recent trials have utilized a 200 mg/day dose of minocycline in studies of Parkinson's disease and acute stroke (Lampl et al. 2007; The NINDS NET-PD Investigators 2006).”
Cited by
Topiramate for the Treatment of Cocaine Addiction: A Randomized Clinical Trial
Johnson, B. A., Ait-Daoud, N., Wang, X.-Q., Penberthy, J. K., Javors, M. A., Seneviratne, C., & Liu, L. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2295 · Cited by 133
Minocycline: Therapeutic Potential in Psychiatry
Dean, O. M., Data-Franco, J., Giorlando, F., & Berk, M. (2012) · CNS Drugs · doi:10.2165/11632000-000000000-00000 · Cited by 131
“Sofuoglu and co-workers([83]) failed to show any advantage of minocycline when compared to placebo on subjective (number of cigarette puffs), biochemical (carbon monoxide and cotinine levels) and performance on the Sustained Attention to Response Test (START).”
BackgroundCocaine craving and use during daily life
Preston, K. L., Vahabzadeh, M., Schmittner, J., Lin, J.-L., Gorelick, D. A., & Epstein, D. H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1655-8 · Cited by 123
“However, during an experimental session, reductions in craving do not necessarily lead to reductions in drug self-administration (Haney and Spealman 2008; Leyton et al. 2005; Sofuoglu et al. 2009).”
BackgroundGlial mechanisms underlying substance use disorders
Linker, K. E., Cross, S. J., & Leslie, F. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14163 · Cited by 64
Metadata
- Authors
- Sofuoglu, M., Waters, A. J., Mooney, M., & O'Malley, S. S.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 92
- Issue
- 1
- Pages
- 135-140
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2125621261
- Cited by
- 37
- References
- 5
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans. https://app.cochat.ai/papers/10.1016/j.pbb.2008.11.004
- The paper
- Sofuoglu, M., Waters, A. J., Mooney, M., & O'Malley, S. S. (2009). Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2008.11.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.